Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascular therapies, announced today that it has raised $26…
Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim…
www.corvidiatx.com Corvidia Therapeutics is a biotechnology company pioneering the next generation of cardiovascular therapies. Founder: Ram Aiyar Source: NIH/MedImmune …